Novartis Q4 net profit rebounds to $2.1 billion
Associated Press :Berlin, Jan 23 2013, 13:16 IST
Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion.
The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.
Novartis said Wednesday that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.
The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.
Previous Story Tata Steel to raise 10 bn rupees via dual tranche bonds Next Story 'Research In Motion' sets stage for clients to run BlackBerry 10 devices
Reader's Comments| Post a Comment
Be the first to comment.
